RxDoctor Payments Data
★ My doctorsLook up a doctor →

William McFeely, MD

Otolaryngology · Huntsville, ALNPI 1962593442

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $58,720 of the $69,723 with a category attached, or 84.2%. Stryker accounts for 98.6% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2022 at $42,359 and has fallen 99.8% since, to $70 in 2025. Among otolaryngology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$69,723in general payments, 2019–2025

Across 132 payments — averaging $528.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$69K
  • Integra Lifesciences Corporation$179
  • Optinose US, Inc.$152
  • Inspire Medical Systems, Inc.$148
  • Kerecis Limited$103
  • Smith+Nephew$97
  • plus $270 from 10 others
$24,710in research payments, 2019–2025

Across 13 payments — averaging $1900.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Aerin Medical Inc.$21K
  • Neurent Medical Limited$4K

What the payments were for

  • Consulting fees$58,72084%
  • Travel & lodging$7,11210%
  • Food & beverage$3,8926%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker100$68,774
Integra Lifesciences Corporation3$179
Optinose US, Inc.10$152
Inspire Medical Systems, Inc.1$148
Kerecis Limited4$103
Smith+Nephew2$97
Sanofi2$70
Regeneron Healthcare Solutions, Inc.2$49
Cochlear Americas1$39
GSK1$27
KARL Storz Endoscopy-america1$18
Hikma Pharmaceuticals USA1$17
Arbor Pharmaceuticals, Inc.1$14
Merck1$13
Hologic Sales And Service, LLC1$12
Intersect ENT, Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$69,723 in reported general payments places this provider in the 95th percentile of 155 otolaryngology providers in Alabama.

See all otolaryngology providers in Alabama →

Medicare billing

Part B allowed, 2024
$187,612
Medicare patients
615
Services billed
2,903

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth111$17,766
Azelastine Hcl193$6,037
Indapamide214$4,156
Methazolamide13$2,360
Fluticasone Propionate118$2,155
Ofloxacin71$1,881
Fluocinolone Acetonide Oil33$1,802
Ondansetron OdtOndansetron76$1,080
Sulfacetamide Sodium31$978
Meclizine Hcl78$929
Ipratropium Bromide11$460
Amitriptyline Hcl70$451
Diazepam208$438
Montelukast Sodium37$427
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav34$371

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Huntsville

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →